Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Infinity Pharmaceuti (INFI)

2.24 0.04 (1.82%)

04-20 16:00

Open:

2.24

Pre. Close:

2.2

High:

2.25

Low:

2.16

Volume:

377,923

Market Cap:

116M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.253 - 2.262

2.262 - 2.271

Low:

2.138 - 2.148

2.148 - 2.157

Close:

2.224 - 2.24

2.24 - 2.255

Technical analysis  (as of: 2018-04-20 4:30:51 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 2.75     One year: 3.12

Support:

Support1: 1.85    Support2: 1.54

Resistance:

Resistance1: 2.36    Resistance2: 2.67

Pivot:

2.09

Moving Averages:

MA(5): 2.21     MA(20): 2.11

MA(100): 2.09     MA(250): 1.83

MACD:

MACD(12,26):     Signal(12,26,9): -0.02

%K %D:

%K(14,3): 73.47     %D(3): 72.79

RSI:

RSI(14): 53.74

52-Week:

High: 3.75  Low: 0.93  Change(%): 14.3

Average Vol(K):

3-Month: 76430  10-Days 76850

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
INFI has closed below upper band by 20.8%. Bollinger Bands are 14.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-12T18:20:00-04:00
Daily Insider Ratings Round Up 4/11/18: INFI, ETM, LGCY, CCUR, OPK, DEX

2018-03-27T14:39:25-04:00
Infinity Pharmaceuticals (INFI) Presents At BioCentury's 25th Annual Future Leaders In The Biotech Industry Conference - Slideshow

2018-03-26T08:32:00-04:00
Infinity to Present at Two Upcoming Conferences

2018-03-21T11:36:00-04:00
Infinity To Present At BioCentury's 25th Annual Future Leaders In The Biotech Industry Conference

2018-03-15T21:28:07-04:00
Infinity Pharmaceuticals' (INFI) CEO Adelene Perkins on Q4 2017 Results - Earnings Call Transcript

2018-03-15T16:20:15-04:00
Infinity Pharmaceuticals beats by $0.11

2018-03-15T16:05:00-04:00
Infinity Pharmaceuticals Provides Company Update and Reports Fourth Quarter and Full Year 2017 Financial Results

2018-03-11T15:56:09-04:00
Week 11 Breakout Forecast: Short-Term Picks To Give You An Edge

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

51.96

Shares Float (M)

49.18

% Held by Insiders

5.50

% Held by Institutions

48.90

Shares Short (K)

2815

Shares Short Prior Month (K)

2070

Stock Financials

EPS

-0.830

EPS Est. Current Year

-0.920

EPS Est. Next Year

-1.500

EPS Est. Next Quarter

-0.200

Forward EPS

-0.591

Book Value (p.s.)

2.450

PEG Ratio

-0.03

Profit Margin

Operating Margin

-607.42

Return on Assets (ttm)

-45.2

Return on Equity (ttm)

-64.3

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.616

Qtrly Earnings Growth

Operating Cash Flow (M)

-36.71

Levered Free Cash Flow (M)

-24.21

atoplab.com

Valuation

P/E

-2.70

P/E Growth Ratio

0.02

P/BV

0.91

P/S

969920000.00

P/CF

-3.17

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.